Stay updated on FG-4592 and Rosiglitazone Interaction Clinical Trial
Sign up to get notified when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.

Latest updates to the FG-4592 and Rosiglitazone Interaction Clinical Trial page
- Check5 days agoChange DetectedThe page now shows a newer site revision tag (v3.6.6) replacing the previous tag. This indicates a minor platform update that changes only the presentation and not the study data.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, signaling a new release of the page. This likely reflects a minor update to the page structure or accompanying information.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, representing a new build of the site with potential bug fixes or minor UI adjustments.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates an updated version of the study record page.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.6.2 was added and the previous Revision: v3.6.0 was removed, updating the page's version label.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded recruitment status 'No longer looking for participants' and introduced new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The change also adjusts the Intervention/Treatment heading formatting and includes the site revision note Revision: v3.6.0.SummaryDifference1%

Stay in the know with updates to FG-4592 and Rosiglitazone Interaction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-4592 and Rosiglitazone Interaction Clinical Trial page.